Exhibit 107.1
CALCULATION OF FILING FEE TABLE
FORM S-8
(Form Type)
Galera Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table I: Newly Registered Securities
| Plan | Security Type |
Security Class Title |
Fee Calculation Rule |
Amount Registered(1) |
Proposed Maximum Offering Price Per Unit |
Maximum Offering Price |
Fee Rate |
Amount of Registration Fee | ||||||||
| 2023 Employment Inducement Award Plan | Equity | Common Stock, par value $0.001 per share | Rule 457(c) and 457(h) |
1,500,000(2) | $3.16(3) | $4,740,000.00 | $110.20 per million dollars | $522.35 | ||||||||
| Total Offering Amounts | $4,740,000.00 | $522.35 | ||||||||||||||
| Total Fee Offsets | $— | |||||||||||||||
| Net Fee Due | $522.35 | |||||||||||||||
| (1) | In accordance with Rule 416(a) under the Securities Act of 1933, as amended (“Securities Act”), this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued under the Galera Therapeutics, Inc. 2023 Employment Inducement Award Plan (the “Inducement Plan”) to prevent dilution resulting from stock splits, stock dividends or similar transactions. In addition, pursuant to Rule 416(c) under the Securities Act, this registration statement also covers an indeterminate amount of interests to be offered or sold pursuant to the Inducement Plan. |
| (2) | Consists of 1,500,000 shares of Common Stock that may become issuable under the Inducement Plan pursuant to its terms. |
| (3) | Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act of 1933, as amended, and based upon the average of the high and low prices of the Common Stock as reported on the Nasdaq Global Market on May 4, 2023. |